Separation of pluripotent stem cells and early B lymphocyte precursors with antibody Fall-3 by unknown
Separation of Pluripotent Stem Cells and Early B
Lymphocyte Precursors with Antibody Fall-3
By Christa E. Miller-Sieburg
From the Medical Biology Institute, La Jolla, California 92037
Summary
A major goal in the study of hematopoiesis is to obtain populations of primitive stem cells,
free of restricted and mature cells. We previously showed that a small population of normal
bone marrow, the Thy-11°Lin - cells, was highly enriched for pluripotent stem cells that
repopulate lethally irradiated mice. These cells also differentiated along the B lymphocyte lineage
in response to the stromal elements in Whitlock-Witte cultures. These two hematopoietic activities
were entirely contained in and were enriched to similar extents in the Thy-11°Lin - population.
Here we show for the first time that these two activities can be resolved functionally and
phenotypically. The cells that respond to the stroma in lymphoid culture are more sensitive to
the cytotoxic drug 5-Fluorouracil than are stem cells. Furthermore, we have derived a new
monoclonal antibody, Fall-3, that detects primitive stem cells but does not label the B cell precursor.
This indicates that the small Thy-11°Lin- population is heterogeneous, containing precursors
restricted to the B cell lineage as well as pluripotent stem cells. Antibody Fall-3 defines a novel
stem cell antigen, expressed on all primitive stem cells and thus, will be useful in the further
characterization and isolation of both stem cells and B cell precursors.
One central issue in hematopoiesis is the characterization
of the most primitive pluripotent hematopoietic stem
cell. It is well established that a single pluripotent stem cell
can give rise to cells of all hematopoietic lineages, the lym-
phocytes, the myeloid and the erythroid cells (1-3). How-
ever, little is known about the process ofcommitment when
stem cells differentiate into restricted precursors. Of partic-
ular interest is the differentiation stage at which commitment
to the lymphocyte lineages occurs. Identification of this cell
would allow to determine whether the stem cell commits
directly to T and B cell precursors or via a common lympho-
cyte progenitor. Also, it is unclear whether commitment to
the B cell lineage coincides with Immunoglobulin gene rear-
rangement. Thus, to define the differentiation events between
stem cells and lymphocyte precursors and to analyze what
regulates this transition it is critical to separate these cells
functionally and phenotypically.
Considerable progress has been made in obtaining popula-
tions highly enriched for hematopoietic stem cells from normal
mouse bone marrow (4-10). Pluripotent stem cells are defined
through their function, namely by their capacity to repopu-
late all hematopoietic lineages in a compromised host. Be-
sides beingable to repopulate lethally irradiatedanimals, cells
in these stem cell enriched populations are active in a variety
of in vitro and in vivo assays. For example, stem cell enriched
populations have been shown to contain spleen colony-forming
units (CFU-S)t in vivo (4-9), to give rise to osteoclasts in
I Abbreviations used in this paper. CFU-C, colony-forming unit culture;
CFU-S, spleen colony-forming unit; 5-FU, 5-fluorouracil.
vitro (11), to generate T lymphocytes upon intra-thymic in-
jection (6), to respond to the stroma in both Dexter and
Whitlock-Witte conditions (4,12), and to give rise to mixed
myeloid-erythroid colonies upon stimulation by IIr3 (5). In-
deed, the purity of enriched stem cellspopulations often has
been gauged on the basis of clonal responses in these assays
as most stem cell assays that are based on repopulation ca-
pacity in vivo do not readily allow quantification.
However, it has been difficult to resolve whether pluripo-
tent stem cells themselves respond to these environmental
stimuli or whether the stem cell enriched populations also
contain lineage restricted precursors whose activity was de-
tected in the various assay systems. In fact, one ofthese clonal
assays that hadbeen previously believed to measure stem cells,
the CFU-S assay, detects restricted myeloid-erythroid pre-
cursors and not stem cells (13, 14). This indicates that all
stem cell enriched populations described to date contained
some lineage restricted precursors. Restricted precursors may
interfere with or enhance stem cell activity in bone marrow
transplantation and in studies designed to identify regula-
tory signals specific for stem cells. Thus, it is important to
define the cellular composition of these stem cell enriched
populations.
One of these stem cell enriched populations, the Thy-
11°Lin - population, is active in most of the assays described
above (4-6). It has been reported that the Thy-11°Lin- popu-
lation can be subdivided phenotypically using the cell sur-
face marker Sca-1 (6). Both the Thy-11°Liii - population and
the stem cell enriched Sca-l-positive subpopulation contain
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cells, restricted myeloid-erythroid precursors. However, the
question whether the Thy-11°Lin- population contains ad-
ditional restricted precursors particularly, precursors committed
to the lymphoid lineages, was not addressedin thesereports.
Here we present evidence for further heterogeneity in the
Thy-1a°Lin- population. We show that the Thy-11°Lin -
population contains a precursor restricted to the B cell lin-
eage in addition to pluripotent stem cells. This B cell precursor
is characterized by its capacity to establish lymphoid Whitlock-
Wittecultures in limiting dilution. B cell precursors andstem
cells can be distinguished functionally and phenotypically.
A monoclonal antibody, designated Fall-3 that we have de-
rived, allows for the first time the separation of these cells
and will be helpful in the further characterization andisola-




BALB/c and C57BL6-Ly-5.2 mice were bred either
at the Lilly Research facility (LaJolla, CA) or at the Medical Bi-
ologyInstitute (LaJolla, CA).C57BL6-Ly-5.2 mice were obtained
originally from Dr. E. Boyse(Sloan-Kettering Cancer Center, New
York). 3- to 5-wk-old mice were injected i.v. with a single dose of
150 mg 5-Fluorouracil (5-FU) (Sigma Chemical Co., St. Louis, MO)
per kilogram body weight in saline containing 0.1 M NaHCO3
whereindicated. C57B1/6mice, used as hostsin reconstitution ex-
periments at 3-6 mo-of-age, were either purchased from Jackson
Laboratories (Bar Harbor, ME)or bred at the Medical Biology In-
stitute facility.
Derivation ofMonoclonal Antibody Fall-3.
￿
Lewis Rats were in-
jected i.p. and s.c. with 5 x 105 to 106 mouse bone marrow cells
depleted of cells that express 11220, Gr-1, or Mac-1. Cells were in-
jected three times at 14-d intervals. 3dafter thelast immunization
spleen cells were fused to themouse myeloma X63Ag8-653 (15).
Supernatants ofhybrids were screened on mousebone marrow cells
by immunofluorescence. mAb Fall-3 wasdetected with goat anti-
rat-FITC antibodies (Caltag, SouthSanFrancisco, CA). Aftersub-
cloning of antibody-producing hybrids, mAb were prepared from
serum-free culture supernatant by precipitation with 50% satu-
ratedammonium sulfate. Theisotype of mAb Fall-3 is IgM as de-
termined in adouble diffusionassay using aratisotyping kit(ICN
ImmunoBiologicals, Costa Mesa, CA).
Stem Cell Assay.
￿
To measurestem cellswe used acombination
of theradioprotection andlong-termrepopulation assays as described
previously (5). Briefly, C57BL/6mice were lethally irradiated with
1,140rads (2 dosesof 570rads)andreconstituted i.v. with different
numbers ofbone marrow cells derived from pools of 3-5 Ly-5 con-
genicC57BL6-Ly-5.2 mice. Agematchedcohorts of6-10 mice were
injected foreach cell dose. The extent of repopulation in surviving
mice was determined 3 to 5 mo later by staining peripheral blood
cells. Blood was collected into EDTA solution (3 mg EDTA per
ml PBS) and incubatedwith 2% Dextran for30 min at 37°C, fol-
lowedby lysis ofresidual erythrocytes with Gey's solution. White
blood cells were labeled with a biotinylated antibody specific for
thedonor type Ly-5.2 marker detected by Avidin-FITC. A cell line,
A-20, secreting antibodies specific for Ly-5.2 was thegenerous gift
of Dr. S. Kimuro, (Sloan-Kettering Cancer Center, NY).TheLy-5
marker is expressed on most hematopoietic cells with the excep-
tion oferythroidcells (16). To determine therestoration ofindividual
lineages, whitebloodcells were costained with antibodies specific
for11220(mAb Ra3-6112), Mac-1 (mAb M1/70), Gr-1 (mAb Ra3-
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8C5), and Thy-1 (mAb 31-11). In all mice tested, donor derived
T, B, andmyeloid cells were reconstituted in ratios comparable to
that seen in unirradiated mice.
This assaydoes not readily allow the quantification of stem cell
frequency. To compare stem cell level we introduce the "stemcell
unit"whichwe define as thenumber ofnormal bone marrow cells
needed to completelyrepopulate 50%oflethallyirradiated animals.
Therefore, 1 stem cell unit = 8 x 10° cells = 100% stem cell
activity (see Fig. 1) . Further, we calculate: % stem activity in 5-FU
bone marrow = 1 stem cell unit/No. of cellsfor50% reconstitu-
tion (5-FUbm); stem cell activity perfemur = (cells per femur/1
stem cell unit) x % stem cell activity; % stem cell activity per
femur = stem cell activity perfemur 5-FU bone marrow/stem cell
activity .per femur normal bone marrow.
Cell Separations andImmunofuorescence Analysis.
￿
Bone marrow
cellswere incubated with a saturating concentration ofmAb Fall-3
detected 'vvith goat anti-rat-FITC antibodies (Caltag). Cells were
then separated into Fall-3' and Fall-3 - subpopulations with a
multi-laser cell sorter at the Flow Cytometry Laboratory at the
Salk Institute for Biological Studies (LaJolla, CA). Thebackground
level for the staining was determined by using either an isotype
matchedantibody (Fall-84) detected with goat anti-rat-FITC anti-
bodies orjust theFITC-labeled second stageantibodies.Theback-
ground levels determined with these controls did not differ
significantly.
For two color immunofluorescence, mAb Fall-3 was detected
with PE-labeled goat anti-rat antibodies (Caltag). Cellswere washed
and then incubated for 1 to 2 min with 25% normal rat serum
(Cappel Laboratories, Cochranville, PA), followed by biotinylated
lineage specific antibodies (4, 5) detected with Avidin-FITC (Vector
Labs, Burlingame, CA). The hybridoma cell line secreting anti-
body E13 161-1, specific for Sca-1 (6) was obtained from Dr. L.
Weissman (Stanford University, CA).
Colony-Forming Assay/Colony-Forming Unit Culture (CFU-C)and
Cytokines. Unseparated bone marrow cells or sorted subpopula-
tions derived from 3- to 4-wk-old BALB/c or C57-Ly-5.2 mice were
plated in 0.8% (w/v) methylcellulose, supplemented with 11,3 at
400 U/ml, as described previously (5). Recombinant IL3 (17) in
the form of supernatants of appropriately transfected Cos 7 cells
wasagenerous gift ofDr. D. Rennick(DNAXResearch Institute,
Palo Alto, CA). Colonies consisting of 50 or more cells were scored
after9-11 dofculture. In some experiments colonies were counted
again after 3 wk of culture.
Limiting Dilution AnalysisforStroma-Responsive Cells.
￿
This assay
has been described in detail (4, 18, 19). Briefly, the monoclonal
stromal cell line AC-3.5 or its subclone AC-3.GG was seeded into
the wells of 96-wellplates in RPMI supplemented with 5% FCS
Q.R. Scientific, Woodland, CA) and 5 x 10-'M 2-ME. Cultures
were rechargedwith graded doses ofbone marrow cells (one plate
foreach cell concentration) 2to 4dlaterandthen were fedweekly.
Wells that contained colonies of at least 103 small lymphoid cells
were scored by phase microscopy after 10 to 14 d of culture ac-
cording to morphological criteria. Some experiments were evalu-
ated again 3 wk post reseeding. We showed previously that this
assay is linear, and, in fact, detects B lineage cells as all colonies
tested contained cells that expressed theB lineage specific marker
11220 (4, 19).
Results
Stem Cell Contentin Normaland5-FU Treated Bone Marrow.
5-FU hasbeen usedpreviously to define hematopoieticdifferen-tiation stages (20-26). It has been reported that mature cells
and late precursors are more sensitive to this drug than primi-
tive precursors or stem cells. We used a single injection of
5-FU to determine whether this treatment would reveal het-
erogeneity in the Thy-11°Lin- populations by differentially
affecting two activities completely contained within this popu-
lation: stem cell activity as assessed in a long-term repopula-
tion assay and the capacity to respond to stromal cells with
B cell differentiation. We reasoned that a differential effect
of 5-FU on these activities would indicate that the activities
are carried by different cells, co-enriched in the same popu-
lation.
Since all stem cells are found in the Thy-11°Lin- popula-
tion (5), stem cell content measured in unseparated bone
marrow reflects stem cell content in the Thy-11°Lin- popu-
lation. The levelof stem cells in the bone marrow ofnormal
mice and of mice at day 2, day 4, and day 10 after injection
of 5-FU was measured in a long-term repopulation assay in
lethally irradiated mice. Host mice were injected with graded
doses of donor cells derived from mice that differed in the
Ly-5 locus. Peripheral bloodcells of surviving mice were stained
with a mAb specific for donor type Ly-5 to determine the
extent ofrepopulation. As previously described (27), a number
of surviving animals that received low doses of stem cells
showed considerable host derived reconstitution. For easier
comparison of stem cell activity, the percentage of mice that
were completely reconstituted by donor cells (> 80%) are
depicted in Fig. 1. To allow the survival of 50% of the lethally
irradiated animals for at least 3 mo and to obtain > 80%
reconstitution by donor type cells in these mice, 8 x 104





number of cells injected
Figure 1.
￿
Pluripotent hematopoietic stem cells in normal and 5-FU bone
marrow . Stem cellsin bone marrow ofnormal (x), 5-FU day2(O), 5-FU
day 4 ([1), and 5-FU day 10 (") bone marrow were titrated in the ra-
dioprotection assay. Graded doses of cells derived from C57-Ly-5.2 mice
were injected into lethally irradiated congenic C57BL/6 mice (Ly-5.1).
Full titration using 5 to 6 mice per group was done once. Mid-range in-
dividual concentration points were repeated 2to 3times. Peripheral white
bloodcells ofsurviving mice (a:3 mo) were stained with an antibody specific
for the Ly-5.2 antigen to determine the extent of repopulation by donor
cells in individual mice. The percentage of mice that contained D80%
ofdonor (Ly-5.2) cells in their blood is used to compare stem cell levels.
The dose ofbone marrow cells at which 50% of the animals were fully
reconstituted is indicated in the figure.
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experiments. The levelof pluripotent stem cells was reduced
fourfold in 5-FU day 2 bone marrow, while the level ofstem
cells in 5-FU day 4 bone marrow was similar to that found
in normal marrow. Bone marrow from mice treated 10 d pre-
viously with 5-FU contained a fourfold higher level of stem
cells.
B Cell Precursors in 5-FU Treated Bone Marrow . Thy-
11°Lin - cells also respond with high frequency to the micro-
environment in Whitlock-Witte bone marrow cultures by
differentiating alongthe B cell lineage. These stroma-respon-
sive cells are also entirely contained within the Thy-11°Lin-
population (4). Thus, the capacity to respond to the stromal
cells in Whitlock-Witte cultures ofunseparated bone marrow
reflects this activity in the Thy-11°Lin- population. We
wished to determine whether the capacity to give rise to B
lineage cells in culture was affected by 5-FU to the same or
different extent as the capacity to repopulate irradiatedanimals.
The frequency of cells that give rise to colonies of at least
103 small lymphoid cells in limiting dilution on the mono-
clonal stromal line AC-3.5 is decreased at least 10-fold in 5-FU
day 2 and reduced six-fold in 5-FU day 4 bone marrow com-
pared to normal marrow (Table 1). In contrast, 5-FU day
10 bone marrow contains a four-fold higher frequency of B
cell precursors than normal bone marrow. The cultures were
counted generally at 2 wk. To determine whether cellsfrom
5-FU treated bone marrow have a delayed response to stromal
cellswe also evaluated the cultures at 3 wk (data not shown).
In agreement with previous observations on normal bone
marrow cells (18), we did not observe additional colonies.
Differential Effects of 5-FU.
￿
Both radioprotecting and
Sroma-responsive cells were affected by 5-FU. However, their
kinetics of recovery was markedly different. Fig. 2 summa-
rizes and compares the data presented in Table 1 and Fig.
1. Since the radioprotection assay does not allow readily to
calculate frequencies we have used stem cell units for com-
parison (see Materials and Methods for calculations). The fre-
Table 1.
￿
Frequency of B Cell Precursors that Respond to the
Stromal Cell Line AC-3-GG in Whitlock-Witte Cultures
in Limiting Dilution
" Data (t SD) shown are from two representative experiments. Cul-
tures were evaluated 2 wk post seeding.
t Data in this column are derived by calculation from the frequency data
to facilitate comparison. Values have been rounded to the next integer.











None 10 t 2 800 ± 300 12 12 x 103
Day 2 9 t 1 9,167 ± 849 1 10,
Day 4 4 ± 2 5,600 ± 900 2 103
Day 10 1 .5 ± 1 170 ± 25 58 9 x 143Figure 2 .
￿
Kinetics of recovery ofhematopoietic activities after a single
injection of 5-FU. Data are compiled from Fig. 1 and Table 1 . Activity
innormalbonemarrow was set at 100% . For calculation of stem cell units
see Materials and Methods. (A) Comparison of the level or frequency of
activities ; (B) Comparison of activities based on numbers per femur taking
in account the reduced cellularity in 5-FU bone marrow.
quency ofB cell precursors and the stem cell level in normal
bone marrow was set as 100% . In 5-FU day 2 bone marrow
these activities were reduced to 8 and24%, respectively (Fig.
2 A) . In 5-FU day 4 bone marrow stem cell levels are the
same as in normal bone marrow, while the frequency ofB
cell precursors is only 16% ofnormal. Both activities are en-
riched in 5-FU day 10 bone marrow.
However, injection of5-FU reduces the cellularity ofbone
marrow in a time dependent manner. We obtained 9, 4, and
1.5 million cells per femur from mice 2, 4, and 10 d respec-
tively after 5-FU treatment . Therefore, we calculated B cell
precursor and stem cell activity per femur in normal and5-FU
treated mice (Fig. 2 B) . When the stem cell content ofnormal
bone marrow is set as 100%, stem cells in 5-FU day 2, day
4, and day 10 are 22, 40, and 54% of normal, respectively .
Thus, the absolute number of stem cells is not fully recov-
ered over the time span examined. This indicates that the
increase in stem cell level seen in 5-FU day 10 may be due
to elimination ofother cells rather than an expansion of stem
cells. Similarly, the absolute number ofstroma-responsive cells
is reduced at all time points analyzed . We found 8, 6, and
75% of the normal response in 5-FU day 2, day 4, and day
10 bone marrow, respectively. However, 5-FU depletes stroma-
responsive cells significantly more than radioprotecting cells.
This difference is most pronounced in 5-FU day 4 bone
marrow (Fig . 2 B) . Thus, the kinetics of recovery following
5-FU treatment differ for pluripotent stem cells and B cell
precursors .
Antibody Fall-3 Separates Stem Cellsfrom B Cell Precursors.
The kinetics of recovery after 5-FU treatment indicates that
the hematopoietic activities found in the Thy-V°Lin- popu-
lation in normal bone marrow reflect heterogeneity in this
population rather than multiple capacities of the same cell
(Fig. 2) . To define further the cells that carry these activities,
we separated normal bone marrow with monoclonal anti-
body Fall-3. We derived this antibody from a fusion designed
to detect subpopulations in bone marrow depleted ofmature
cells .
Antibody Fall-3 (IgM) stains 15 to 30% of normal bone
marrow (Fig. 3) . Cells from CBA/J, BALB/c, and C57BL/6
mice are detected to a similar extent . Only minor popula-
tions (ti5%) ofspleen, thymus, and Peyer's patches cells were
stained above background . Two-color immunofluorescence
analysis indicates that less than5% of the mature bone marrow
cells that express that the lineage markers B220, Gr-1, Mac-1,
Thy-1, or CD-8 bear also the Fall-3 determinant (data not
shown) . This suggests thatmAb Fall-3 detects preferentially
cells that are not mature granulocytes, macrophages, T or
B lymphocytes .
Cells that expressed the cell surface determinant detected
by mAb Fall-3 contain most if not all pluripotent stem cells
that repopulate all lineaggs in irradiated mice (Fig. 4 A) . Only
mice that received Fall-3+ cells were stably reconstituted at









Forward angle light scatter (488nm)
Figure 3.
￿
Immunofluorescence profile of normal bone marrow cells
stained withmAb Fall-3 . A singlecell suspension ofbone marrow derived
from CBA mice was incubated with saturating concentrations of mAb
Fall-3, detected with FITC-conjugated goat anti-rat antibodies. Displayed
are Forward Scatterversus fluorescence intensity ; the corresponding histo-
grams are depicted on the y and x axis . The gate used to separate positive





number ofcellsinjected 10 5
Figure 4.
￿
Distribution ofhematopoieticactivities in sorted Fall-31 and
Fall-3 - bone marrow populations. (A) Extent ofrepopulation by graded
doses of sorted Fall-3+ (") or Fall-3 - (O) cell populations. Groups of
5to 6mice were injected percell dose. Peripheral bloodcells were stained
for the donor-type Ly-5.2 marker at 5 mo post injection. Donor type T
cells, B cells, andmyeloid cells were reconstituted in normal proportions
in all mice (data notshown). Thefull titration was done once. An inde-
pendent experiment using a single dose (4 x 104 cells per mouse) gave
comparable results. (B) Clonogenic response. 11,3 responsive colonies were
evaluated after 10 d of culture, CFU-S at 12 d post injection, and B cell
precursors after 2 wk of culture. Data are expressed as activity per 104
cells seeded or injected. Fall-3+ (E]), Fall-3- (/).
injected with Fall-3 - cells showed less than 45% donor type
cells at 5 mo post reconstitution. Currently, we are analyzing
whether this low level of reconstitution by Fall-3 - cells is
due to a distinct subset of stem cells or due to a few con-
taminating Fall-3+ cells in the sorted Fall-3- population.
In contrast to most radioprotecting stem cells, B cell
precursors that respond to the microenvironment in Whitlock-
Witte cultures are found predominantly in the Fall-3 -
population (Fig. 4 B). Thus, pluripotent stem cells and B
cell precursors that respond to stromal cells can be separated
by their different cell surface phenotype. Interestingly, CFU-C
that form a colony upon stimulation with IL3 and day 12
CFU-S are found both in the Fall-3 + and the Fall-3- popu-
lations (Fig. 4 B).
We have analyzed the interrelationship of two early hema-
topoietic activities contained exclusively in the Thy-11°Lin -
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population. The activities are radioprotecting stem cells and
B cell precursors that initiate Whitlock-Witte cultures. Both
activities are affected by 5-FU. However, these activities show
markedly different kinetics of recovery and are affected to
different degrees by 5-FU (summarized in Fig. 2). At 4 d
post 5-FU treatment, cells that respond to the stroma in
Whitlock-Witte cultures are depleted more strongly than the
cells that repopulate irradiated animals. Furthermore, the
former cells recover slower than radioprotecting stem cells
after a single injection of 5-FU. This indicates that the ca-
pacity to respond to stromal cells with B cell differentiation
is carried by restricted precursors contained in the Thy-
11°Lin - population and not by stem cells themselves. Most
importantly, B cell precursors and stem cells bear different
cell surface antigens and can be separated with mAb Fall-3.
Thus, the Thy-11°Lin - population is functionally and pheno-
typically heterogeneous and contains restrictedprecursors for
the B cell lineage in addition to stem cells.
We compared B cell precursors and stem cells in 5-FU day
2, 4, and 10 bone marrow. The most pronounced difference
between these two activities was observed at day 4 post 5-FU
treatment. The higher incidence of stem cells at this time
point could be a reflectionof the less severe reduction ofthis
activity earlier in the time course. Alternatively, it is tempting
to speculate that the kinetics reflect a precursor progeny rela-
tionship. Stem cells may have to replenish themselves to a
certain level before being able to generate the B cell precursors.
A more detailed analysis involving more time points is neces-
sary to resolve this issue.
Stem Cells in 5-FU Bone Marrow.
￿
The frequency of ra-
dioprotecting stem cells is enriched in 5-FU day 10 bone
marrow when compared to normal marrow. However, we
found that the reduction in cell number caused by 5-FU treat-
ment outweighs this enrichment and the absolute number
of stem cell units per femur is reduced in bone marrow of
5-FU treated mice over the whole time span tested. Nakano
and colleagues reported that the cells that reconstitute
erythropoiesis in anemic W/W° mice were enriched in 5-FU
day 2 bone marrow and depleted in 5-FU day 4 marrow when
tested in the competitive repopulation assay (26). Using the
same assay, Lerner and Harrison (28) did not find any effect
of 5-FU on stem cells 2 to 15 d afterinjection. These results
could be reconciled to ours by considering the ages of the
5-FU treated animals. We used 3- to 5-wk-old mice whereas
the other studies used adult mice. It is conceivable that stem
cells are expanding in young animals resulting in more 5-FU
sensitive stem cells in young mice than in older mice.
Besides the difference in the age of the animals, different
assay systems for stem cells were used. We define stem cells
by their capacity to rescue and fully repopulated lethally ir-
radiated animals. In the competitive repopulation assay the
stem cells measured are not necessarily required for survival
of the animals as an alternative (competitive) source of stem
cellsis provided. It is possible that the stringent radioprotec-
tion assay reveals damages in the stem cell compartment that
could not be revealed with other assays. It has been reported
that a single injection of 5-FU resulted in long-term impair-













01 8 0functional activities were seen for at least 3 wk (25). These
results are compatiblewith a reduction ofstem cellsby 5-FU
as seen in our study.
When we compared the capacity to repopulate mice and
the ability to respond to stromal cells, we used two assay
systems that required different time spans for completion.
The B cell precursor activitieswere evaluated after 2 wk while
the radioprotection assay required 3 mo to ascertain repopu-
lation by stern cells. However, mice that did not receive stem
cells died 2 to 3 wk after grafting, indicating that the ra-
dioprotection assay requires stem cells to be active at this time.
The B cell precursor assay was carried up to 3 wk without
revealing additional colonies. Thus, it seems unlikely that the
difference in recovery rates of stem cells and B cell precursors
was due to a delay in maturation induced by 5-FU but rather
is a reflection of different cell types.
Another activity enriched in the Thy-11°Lin- population,
the capacity to form multilineage colonies in response to 11,3,
is also affected by 5-FU. We found 0.2, 10, and 129% of
the normal response in Thy-11OLin- cells sorted from 5-FU
day 2, day 4, and day 10 bone marrow, respectively (5, data
not shown). Consequently, 5-FU appears to affect the CFU-C
even stronger than B cell precursors and radioprotecting stem
cells. This indicates that these myeloid-erythroid precursors
are distinct from B cell precursors and stem cells. Therefore,
the Thy-11OLin- population that contains these activities is
functionally heterogeneous. Treatment with 5-FU can reduce
this heterogeneity. 5-FU day 4 bone marrow contains normal
levels of stem cells but at least six-fold lower frequencies of
B cell precursors and CFU-C (Fig. 2, data not shown). Thus,
the combination of 5-FU treatment and cell sorting, partic-
ularly with mAb Fall-3, may result in improved enrichment
for pluripotent stem cells.
Fall-3.
￿
The antigen defined by mAB Fall-3 is expressed
on all pluripotent stem cells that stably repopulate the majority
of blood cells for >5 mo. Thus, mAb Fall-3 defines a novel
stem cell antigen in the same sense as Sca-1 (6) defines a stem
cell antigen. However, Sca-1(Ly 6A/E) and Fall-3 most likely
detect different antigens. One notable differencebetween these
antibodies is that mAb Fall-3 stains bone marrow of both
Ly-6' and Ly-6b mice to a similar extent while Sca-1 is re-
stricted to cells from strains that carry the Ly-6b allele (29,
30). Sca-1 stains about 7 to 10% ofbone marrow cells, most
of which are B220 positive (31), while Fall-3 detects about
30% ofbone marrow cells, most of which are immature cells.
Unlike Sca-1, mAb Pall-3 stains only few cells in thymus,
spleen or lymph nodes. Furthermore, two color immuno-
fluorescence analysis on bone marrow cells with Fall-3 and
Sca-1 shows that most cells that express one of the antigens
lack the other. Only 1 to 2% ofbone marrow cellsco-express
Fall-3 and Sca-1 (Fig. 5). This small population of cells that
express both antigens can account easily for all pluripotent
stem cells in bone marrow since stem cells comprise a very
minor subset ofbone marrow. Furthermore, the staining pat-
tern and tissue distribution of Fall-3 suggest that this mAb
is not identical to other mAbs that define antigens in the
Ly-6 family (32), or to mAbs specific for Qa-m7, another
antigen expressed on stem cells (8).
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Expression ofFall-3 and Sca-1 antigens on bone marrow cells.
Fresh bone marrow cells from C57BL6-1y-5.2 mice were stained with
anti-Sca-1 mAb E13161-7 detected by PE-labeled goat anti-rat antibodies.
Biotinylated mAb Fall-3 was detected with FITC-labeled Avidin. Displayed
are PE versus fluorescence intensity; the corresponding histograms are
depicted on the y and x axis. The windows used to define positive and
negative populations (see Materials and Methods) are indicated.
While most radioprotecting stem cell activity was found
in the Fall-3+ population, a number of mice that received
Fall-3 - cells survived and contained donor type cells in their
blood 5 mo post reconstitution. In these mice, as in the
Fall-3+ reconstituted mice, donor derived T, B, and myeloid
cells were found. However, in all the mice that received
Fall-3- cells the level of reconstitution was low (Fig. 3 A) .
Currently, we cannot discriminate whether this reflects a stem
cell subset with limited proliferation capacity or whether this
reconstitution is due to a few contaminating Fall-3+ cells in
the Fall-3- population. The level of the determinant de-
tected by Fall-3 varies considerably on positive cells and staining
with mAb Fall-3 does not result in discrete positive and nega-
tive populations (Fig. 2). If stem cells would express low levels
ofthe Fall-3 antigen a few stem cells may have fallen within
the negative population defined by our sorting gate. We are
in the process of testing this hypothesis.
Fall-3 separates most, ifnot all, primitive stem cells from
cells that respond to stromal cells in Whitlock-Witte cultures.
Previously, we characterized in detail the Thy-11OLin` cells
that can be detected in limiting dilution and initiate long-
term (>6 wk) Whitlock-Witte cultures. The absence of B
lineage specific markers, its extensive proliferative capacity,
its failure to be transformed by Abelson virus in vitro (32),
and its delayed differentiation into mature B cells places this
cell very early in the B cell lineage (1). As we are able to
separate this B cell precursor from primitive stem cellsit will
be possible to analyze these Thy-11°Lin- Fall-3 - cells more
thoroughly in vivo and in vitro.
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